AstraZeneca Expands China Biotech Strategy With New Cell Therapy Investment in Shanghai

AstraZeneca Expands China Biotech Strategy With New Cell Therapy Investment in Shanghai

  • March 19, 2026

AstraZeneca is deepening its presence in China’s fast growing biotech sector with plans to build a new cell therapy facility in Shanghai, reinforcing its long term commitment to advanced medical innovation in the region. The investment forms part of a broader expansion strategy

China TCR T Biotech NewCure Secures Fresh Funding for Solid Tumor Push

China TCR T Biotech NewCure Secures Fresh Funding for Solid Tumor Push

  • January 27, 2026

China’s cell therapy sector is drawing renewed investor interest as NewCure Biotech raised more than 200 million yuan, or about $28 million, in a Series B financing round to accelerate development of its TCR T pipeline targeting solid tumors. The round was co